Bittencourt Paulo Lisboa, Couto Cláudia Alves, Ribeiro Daniel Dias
Unit of Gastroenterology and Hepatology, Portuguese Hospital, Salvador, Bahia, Brazil.
Alfa Gastroenterology Institute, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Clin Liver Dis. 2009 Feb;13(1):127-144. doi: 10.1016/j.cld.2008.10.002.
Venous thrombosis results from the convergence of vessel wall injury and/or venous stasis, known as local triggering factors, and the occurrence of acquired and/or inherited thrombophilia, also known as systemic prothrombotic risk factors. Portal vein thrombosis (PVT) and Budd-Chiari syndrome (BCS) are caused by thrombosis and/or obstruction of the extrahepatic portal veins and the hepatic venous outflow tract, respectively. Several divergent prothrombotic disorders may underlie these distinct forms of large vessel thrombosis. While cirrhotic PVT is relatively common, especially in advanced liver disease, noncirrhotic and nontumoral PVT is rare and BCS is of intermediate incidence. In this article, we review pathogenic mechanisms and current concepts of patient management.
静脉血栓形成是由血管壁损伤和/或静脉淤滞(即局部触发因素)与获得性和/或遗传性血栓形成倾向(即全身性血栓形成危险因素)共同作用所致。门静脉血栓形成(PVT)和布加综合征(BCS)分别由肝外门静脉和肝静脉流出道的血栓形成和/或阻塞引起。几种不同的血栓形成性疾病可能是这些不同形式的大血管血栓形成的基础。虽然肝硬化性PVT相对常见,尤其是在晚期肝病中,但非肝硬化和非肿瘤性PVT很少见,BCS的发病率处于中等水平。在本文中,我们综述了其发病机制和目前的患者管理理念。